<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: PBMD News</title><copyright>Copyright (c) 2013 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=pbmd</link><description>Latest Financial News for Prima BioMed Ltd</description><language>en-US</language><lastBuildDate>Fri, 17 May 2013 02:35:19 GMT</lastBuildDate><image><url>http://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gif</url><title>Yahoo! Finance: PBMD News</title><link>http://finance.yahoo.com/q/h?s=pbmd</link><width>144</width><height>45</height></image><item><title>Prima BioMed Issues the Following Notice to Stockholders of the Company</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-issues-following-notice-023519665.html</link><description>[Marketwired] - Prima BioMed Ltd has announced in pursuant to shareholder approval received at yesterday&apos;s general meeting, the Company has today issued 13,287,500 fully paid ordinary shares to its directors and 1,250,000 ...</description><guid isPermaLink="false">yahoo_finance/2474049836</guid><pubDate>Fri, 17 May 2013 02:35:19 GMT</pubDate></item><item><title>Russell J. Howard to Join Prima BioMed&apos;s Board of Directors</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/russell-j-howard-join-prima-021500431.html</link><description>[Marketwired] - Prima BioMed Ltd is pleased to announce that Russell J. Howard, PhD, will join Prima&apos;s Board as a Non-Executive Director with immediate effect.</description><guid isPermaLink="false">yahoo_finance/143513223</guid><pubDate>Wed, 08 May 2013 02:15:00 GMT</pubDate></item><item><title>Prima Biomed&apos;s CEO Discusses Q1 2013 Results - Earnings Call Transcript</title><link>http://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=13fgu09ms/*http://seekingalpha.com/article/1364281-prima-biomed-s-ceo-discusses-q1-2013-results-earnings-call-transcript?source=yahoo</link><description>[at Seeking Alpha] - Prima Biomed&apos;s CEO Discusses Q1 2013 Results - Earnings Call Transcript</description><guid isPermaLink="false">yahoo_finance/428558853</guid><pubDate>Wed, 24 Apr 2013 01:30:12 GMT</pubDate></item><item><title>Prima BioMed Updates Clinical Leadership Team</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-updates-clinical-leadership-234500809.html</link><description>[Marketwired] - Prima BioMed Ltd is pleased to announce that Holbrook Kohrt, MD, PhD and Pamela Klein, MD have been brought on as senior clinical advisors for the CVac development programs. The two professionals will ...</description><guid isPermaLink="false">yahoo_finance/4253343689</guid><pubDate>Tue, 23 Apr 2013 23:45:00 GMT</pubDate></item><item><title>19 April 2013 Prima BioMed Quaterly Results And Conference Call &gt;&gt;</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125r668dt/*http://www.noodls.com/view/B1BEBF4C6D8308DAA73A5CE4C3A33911FD574C33</link><description></description><guid isPermaLink="false">yahoo_finance/3505466732</guid><pubDate>Fri, 19 Apr 2013 19:05:05 GMT</pubDate></item><item><title>Prima Biomed Quarterly Results and Conference Call</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-quarterly-results-conference-123000160.html</link><description>[Marketwired] - Prima BioMed Ltd today released its Appendix 4C - Quarterly Report for the three month period ending 31 March 2013. The Company had A$25.18 million in cash and term deposits as of the end of the quarter. ...</description><guid isPermaLink="false">yahoo_finance/1372779234</guid><pubDate>Fri, 19 Apr 2013 12:30:00 GMT</pubDate></item><item><title>Prima BioMed awarded Japanese patent for CVac</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-awarded-japanese-patent-111100857.html</link><description></description><guid isPermaLink="false">yahoo_finance/2057738479</guid><pubDate>Wed, 17 Apr 2013 11:11:00 GMT</pubDate></item><item><title>Prima BioMed Awarded Japanese Patent for CVac(TM)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-awarded-japanese-patent-110000678.html</link><description>[Marketwired] - Prima BioMed Ltd is pleased to announce that it has been granted a patent from the Japanese Patent Office that protects methods used in the manufacture of CVac. The method of use claims secured in patent ...</description><guid isPermaLink="false">yahoo_finance/2557053956</guid><pubDate>Wed, 17 Apr 2013 11:00:00 GMT</pubDate></item><item><title>11 April 2013 Share Purchase Plan Offer Documents &gt;&gt;</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=1252s7tdb/*http://www.noodls.com/view/42E13CE961BAE8DEEBAC0F4A4742DEB609EEE099</link><description></description><guid isPermaLink="false">yahoo_finance/3961454697</guid><pubDate>Thu, 11 Apr 2013 19:20:58 GMT</pubDate></item><item><title>09 April 2013 Share Purchase Plan Update &gt;&gt;</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=12554hbph/*http://www.noodls.com/view/FBA4936FDB9EC37CAE62EF61DB6FCC1746B6A96B</link><description></description><guid isPermaLink="false">yahoo_finance/1786330625</guid><pubDate>Tue, 09 Apr 2013 08:50:32 GMT</pubDate></item><item><title>20 March 2013 3.8 million Euro grant to support CVac Development; Prima moving forward with pilot of CVac in additional cancer indications &gt;&gt;</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125jvkrj2/*http://www.noodls.com/view/8510497F407E53E7F235C4A47C6D05E6F09AD439</link><description></description><guid isPermaLink="false">yahoo_finance/3517604230</guid><pubDate>Wed, 20 Mar 2013 12:16:17 GMT</pubDate></item><item><title>3.8 Million Euro Grant to Support CVAC(TM) Development; Prima Moving Forward With Pilot Trials of CVAC in Additional Cancer Indications</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/3-8-million-euro-grant-230000172.html</link><description>[Marketwired] - Prima BioMed Ltd is pleased to announce that the Saxony Development Bank in Dresden, Germany has approved a EUR 3.8 million grant to support CVac development.</description><guid isPermaLink="false">yahoo_finance/2777375492</guid><pubDate>Tue, 19 Mar 2013 23:00:00 GMT</pubDate></item><item><title>Prima BioMed to Present at ISBioTech Annual Meeting</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-present-isbiotech-annual-231450743.html</link><description>[Marketwired] - Prima BioMed Ltd announces that its Vice President of Manufacturing, Marta Schilling, will present at the 3rd annual meeting of the International Society for BioProcess Technology to be held in Rosslyn, ...</description><guid isPermaLink="false">yahoo_finance/1356726543</guid><pubDate>Sun, 10 Mar 2013 23:14:50 GMT</pubDate></item><item><title>Prima BioMed Conference Call to Discuss First Half of Fiscal Year 2013 Results</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-conference-call-discuss-011229812.html</link><description>[Marketwired] - Prima BioMed Ltd today announced it will hold a conference call to discuss its results for the first half of its fiscal year 2013, the period from July 1 through December 31, 2012. The half year report ...</description><guid isPermaLink="false">yahoo_finance/334316064</guid><pubDate>Tue, 05 Mar 2013 01:12:29 GMT</pubDate></item><item><title>Prima Biomed Commences &quot;CANVAS&quot; Clinical Trial in Europe</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-commences-canvas-clinical-003000494.html</link><description>[Marketwired] - Prima BioMed Ltd is pleased to announce that it has commenced recruitment of patients into the CANVAS trial in Europe. Prima has authorized several centers in Ukraine to start enrolling patients. CANVAS ...</description><guid isPermaLink="false">yahoo_finance/3405442465</guid><pubDate>Thu, 28 Feb 2013 00:30:00 GMT</pubDate></item><item><title>04 February 2013 PRIMA BIOMED ANNOUNCES TWO ACCEPTED ABSTRACTS FOR PRESENTATION AT ISCT ANNUAL MEETING &gt;&gt;</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125fpdk2i/*http://www.noodls.com/view/03103A95E3F9590F27E4D94229B791F27965E929</link><description>[at noodls] - Ovarian Cancer About CVac™ Treatment Clinical Trials Announcements 04 February 2013 PRIMA BIOMED ANNOUNCES TWO ACCEPTED ABSTRACTS FOR PRESENTATION AT ISCT ANNUAL MEETING SYDNEY, AUSTRALIA - Prima BioMed ...</description><guid isPermaLink="false">yahoo_finance/2880365609</guid><pubDate>Mon, 04 Feb 2013 20:02:27 GMT</pubDate></item><item><title>Prima BioMed Announces Two Accepted Abstracts for Presentation at ISCT Annual Meeting</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-announces-two-accepted-043000540.html</link><description>[Marketwired] - Prima BioMed Ltd announces that two abstracts related to research and development of CVac™ have been accepted by the International Society for Cellular Therapy for presentation at its 19th annual meeting ...</description><guid isPermaLink="false">yahoo_finance/374353927</guid><pubDate>Mon, 04 Feb 2013 04:30:00 GMT</pubDate></item><item><title>Prima BioMed To Get Key Data In Second Half</title><link>http://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12ltabqvu/*http://seekingalpha.com/article/1143581-prima-biomed-to-get-key-data-in-second-half?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/2996943194</guid><pubDate>Wed, 30 Jan 2013 17:00:40 GMT</pubDate></item><item><title>29 January 2013 Prima Biomed to present at the 15th Annual BIO CEO &amp; Investor Conference &gt;&gt;</title><link>http://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125g21shp/*http://www.noodls.com/view/C15BEEC4655F1341472AC09988137C9F942895E8</link><description>[at noodls] - SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD; ISIN: US74154B2034) (&quot;Prima&quot;, &quot;the Company&quot;) has announced today that Matthew Lehman, its Chief Executive Officer, will ...</description><guid isPermaLink="false">yahoo_finance/3959394525</guid><pubDate>Tue, 29 Jan 2013 12:05:52 GMT</pubDate></item><item><title>Prima BioMed to Present at the 15th Annual BIO CEO &amp; Investor Conference</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/prima-biomed-present-15th-annual-223000297.html</link><description>[Marketwired] - Prima BioMed Ltd has announced today that Matthew Lehman, its Chief Executive Officer, will present at the 15th Annual BIO CEO &amp; Investor Conference on Tuesday, 12 February 2013 at 11:30am Eastern US Time ...</description><guid isPermaLink="false">yahoo_finance/1460321209</guid><pubDate>Mon, 28 Jan 2013 22:30:00 GMT</pubDate></item></channel></rss>